---

---

tags : Fda    symbols : Abt   

save search

---

FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.54% | O: -1.77% H: 0.0% C: -1.81%
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -4.48% | O: -0.22% H: 0.8% C: 0.06%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.72% | O: -1.84% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -3.37% | O: -0.37% H: 1.42% C: 1.37%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.35% | O: -3.44% H: 0.0% C: 0.0%
fda for

---

FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -4.09% | O: -0.29% H: 1.34% C: -0.64%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.1% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -5.02% | O: 0.11% H: 0.37% C: -0.77%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.59% | O: 0.69% H: 0.0% C: 0.0%
fda drug schizophrenia

---

Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -5.08% | O: -0.18% H: 0.47% C: 0.12%
fda device approval heart

---

Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -6.04% | O: 0.38% H: 0.0% C: -1.38%
fda test rapid blood clearance

---

FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| Email alert Add to watchlist
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
fda hepatitis kidney anemia

---

FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -7.26% | O: -0.26% H: 0.0% C: 0.0%
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -2.47% | O: 0.84% H: 1.48% C: 1.29%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.86% | O: 0.3% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -3.65% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -7.5% | O: 1.06% H: 0.0% C: 0.0%
fda rare

---

Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published: 2024-03-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -2.65% | O: -1.58% H: 0.0% C: 0.0%
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -4.88% | O: 0.35% H: 0.99% C: -1.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.81% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -5.0% | O: -0.43% H: 0.41% C: -0.85%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.11% | O: 1.47% H: 0.23% C: -0.19%
fda hypertension

---

Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -2.65% | O: -1.58% H: 0.0% C: 0.0%
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -4.88% | O: 0.35% H: 0.99% C: -1.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.81% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -5.0% | O: -0.43% H: 0.41% C: -0.85%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.11% | O: 1.47% H: 0.23% C: -0.19%
fda hypertension

---

FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published: 2024-03-21 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -2.29% | O: 0.14% H: 0.24% C: 0.24%
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -4.03% | O: 0.0% H: 1.6% C: 0.89%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.83% | O: -0.03% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -5.53% | O: -0.56% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -3.83% | O: 0.3% H: 0.0% C: 0.0%
fda drug iclusig hypertension

---

FDA Approves First Gene Therapy for Rare Pediatric Disease
Published: 2024-03-18 (Crawled : 23:00) - biospace.com/
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -1.09% | O: 0.33% H: 0.13% C: -1.51%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.4% | O: 0.2% H: 0.08% C: -1.14%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -6.18% | O: 1.71% H: 0.36% C: -2.52%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.01% | O: -0.81% H: 0.0% C: 0.0%
fda rare first disease therapy

---

Madrigal’s Rezdiffra, BMS’s Breyanzi Lead Week of Landmark FDA Approvals
Published: 2024-03-15 (Crawled : 15:00) - biospace.com/
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -2.69% | O: -0.62% H: 0.59% C: -1.01%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.85% | O: -1.58% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.37% | O: -5.53% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.03% | O: -0.02% H: 0.0% C: 0.0%
fda breyanzi week

---

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug ...
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -0.69% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.8% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.91% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.31% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

---

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published: 2024-03-11 (Crawled : 14:30) - biospace.com/
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -0.69% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.8% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.91% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.31% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

---

FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa
Published: 2024-03-08 (Crawled : 18:00) - biospace.com/
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| 1.18% | O: 0.98% H: 3.17% C: 0.9%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.42% | O: -0.68% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.4% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.38% | O: -0.08% H: 0.0% C: 0.0%
fda brukinsa approval

---

FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa; Opdivo Approved for B...
Published: 2024-03-08 (Crawled : 17:00) - biospace.com/
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| 1.18% | O: 0.98% H: 3.17% C: 0.9%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.42% | O: -0.68% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.4% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.38% | O: -0.08% H: 0.0% C: 0.0%
fda opdivo approved approval

---

Decision Tracker: FDA Decisions: Amgen’s Bone-Preserving Blockbuster Picks Up Two New Challengers
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.01% | O: 0.0% H: 0.8% C: 0.8%
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| 10.2% | O: -0.15% H: 3.43% C: 3.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.77% | O: -0.67% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.64% | O: -1.65% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.29% | O: -0.45% H: 0.0% C: 0.0%
fda

---

FDA Decisions: J&J’s Rybrevant Becomes First Front-Line Treatment for Type of NSCLC
Published: 2024-03-04 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.9% | O: -0.9% H: 0.0% C: 0.0%
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| 14.09% | O: 0.65% H: 1.13% C: -1.02%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.43% | O: -0.42% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -10.2% | O: 0.03% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -3.95% | O: -0.8% H: 0.0% C: 0.0%
fda first treatment rybrevant

---

FDA Decisions: Multiple Issues Cited in Rejection of Minerva’s Schizophrenia Hopeful
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.89% | O: -1.6% H: 0.0% C: 0.0%
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| 13.74% | O: 0.11% H: 0.98% C: -0.68%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.02% | O: 0.56% H: 0.12% C: -0.38%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.37% | O: 0.22% H: 0.1% C: -1.4%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.28% | O: -0.11% H: 0.0% C: 0.0%
fda schizophrenia

---

FDA Decisions: Multiple Issues Cited in Rejection of Minerva’s Schizophrenia ...
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.89% | O: -1.6% H: 0.0% C: 0.0%
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| 13.74% | O: 0.11% H: 0.98% C: -0.68%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.02% | O: 0.56% H: 0.12% C: -0.38%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.37% | O: 0.22% H: 0.1% C: -1.4%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.28% | O: -0.11% H: 0.0% C: 0.0%
fda schizophrenia

---

FDA Decisions: Allecra Succeeds Where Competitors Failed; Another Humira Copycat
Published: 2024-02-27 (Crawled : 15:00) - biospace.com/
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -6.62% | O: -10.69% H: 0.0% C: -4.98%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.38% | O: -1.07% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -10.35% | O: -0.44% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.76% | O: -0.94% H: 0.0% C: 0.0%
fda humira

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---